drugset / Trial / NCT01659684
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Unknown
300 enrolled
Fondazione Onlus Camillo De Lellis
Azienda Sanitaria Locale di Pescara · collabRegione Abruzzo, Italy · collab
NaSingle-groupOpen-labelPrevention
Summary
Because the potential benefit of standard intravenous immunoglobulins (IVIG) - obtained from unselected donor pools including a varying proportion of donors previously exposed to CMV - has not yet been explored in pregnant women, the investigators performed a longitudinal prospective study on the possible efficacy of IVIG for prevention or therapy of fetal CMV infection.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | standard intravenous immunoglobulin | Protein / enzyme biologic | 0.5 g/kg | Intravenous |